Why are we doing so much cancer gene therapy? Disentangling the scientific basis from the origins of gene therapy

Gene Therapy

Volumn 4, Issue 8, 1997, Pages 755-756

  Lowenstein, P R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS; EDITORIAL; GENE TARGETING; GENE THERAPY; GENE VECTOR; HUMAN; NEOPLASM;

CYSTIC FIBROSIS; GENE TARGETING; GENE THERAPY; GENETIC VECTORS; HUMANS; NEOPLASMS;

EID: 0031203822     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3300494     Document Type: Article

References (4)

1. Roth JA, Cristiano RJ. Gene therapy for cancer: what have we done and where are we going? Cancer Inst 1997; 89: 21-39.
2. Friedmann T. Human gene therapy-an immature genie, but certainly out of the bottle. Nature Med 1996; 2: 144-147.
3. Eck SL, Wilson JM. Gene-based therapy. In: Limbird LE, Hardman JG (eds). Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th edn. McGraw-Hill: New York, 1996, pp 77-101.
4. Dorin JR et al. A demonstration using mouse models that successful gene therapy of cystic fibrosis requires only partial gene correction. Gene Therapy 1996; 3: 797-801.